Progenics Pharmaceuticals makes tender offer for in Exini Diagnostics
Tuesday, October 13, 2015
Progenics Pharmaceuticals Inc has on Oct 13 announced offer to tender all of shares in Exini for a consideration of 3.15 Swedish crowns per share.
Says total value, based on 18,381,081 issued shares in Exini, amounts to about 57.9 million Swedish crowns ($7.1 million).
Offer price represents a premium of about 93 percent compared with EXINI's closing price of 1.63 crows per share on NASDAQ First North Stockholm on Oct. 12.
Board decided to unanimously recommend that shareholders accept offer.
reuters.com
